Concepedia

Kimberly D. Klarmann

KD

Statistics

Publications

29

Citations

2K

H-Index

23

Active since

2004

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

Frederick National Laboratory for Cancer Research

Cancer Genetics (United States)

Science Applications International Corporation (United States)

Kimberly D. Klarmann is an author at National Cancer Institute specializing in life sciences, molecular biology, and cell biology.

Publications per year

2004–2022

29

Publications

29

Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature

Steven Seaman, Zhongyu Zhu, Saurabh Saha et al. · Cancer Cell · 2017 · 447 citations

, , +14

Combined Loss of Cdk2 and Cdk4 Results in Embryonic Lethality and Rb Hypophosphorylation

Cyril Berthet, Kimberly D. Klarmann, Mary Beth Hilton et al. · Developmental Cell · 2006 · 156 citations · Full text

, , +7

Epigenetic Regulation of SOX9 by the NF-κB Signaling Pathway in Pancreatic Cancer Stem Cells

Lei Sun, Lesley Mathews, Stephanie Cabarcas‐Petroski et al. · Stem Cells · 2013 · 141 citations · Full text

, , +17

Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies

Xia Ding, Arnab Ray Chaudhuri, Elsa Callén et al. · Nature Communications · 2016 · 139 citations · Full text

, , +17

C/EBPα deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo

Victoria L. Heath, Hyung C. Suh, Matthew J. Holman et al. · Blood · 2004 · 115 citations · Full text

, , +16

1–5 of 29